Cloned (Comment) | Organism |
---|---|
overexpression of PLD1, PLD2, and their dominant negative forms into Raw 264.7 cells | Mus musculus |
Protein Variants | Comment | Organism |
---|---|---|
additional information | transfection of PLD1, PLD2, and their dominant negative forms into Raw 264.7 cells, only PLD2 overexpression, but not that of PLD1, increases NO synthesis and iNOS expression. LPS-induced NO synthesis and iNOS expression are blocked by PLD2 siRNA, suggesting that LPS upregulates NO synthesis through PLD2. Knockdown of PLD2 with siRNA also decreases phosphorylation of S6K1, p42/44 MAPK and STAT3 induced by LPS | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
macrophage | - |
Mus musculus | - |
RAW-264.7 cell | - |
Mus musculus | - |
Synonyms | Comment | Organism |
---|---|---|
phospholipase D2 | - |
Mus musculus |
PLD2 | - |
Mus musculus |
General Information | Comment | Organism |
---|---|---|
physiological function | importance and activating role of PLD2 for LPS-induced NO synthesis in Raw 264.7 cells with involvement of the S6K1-p42/44 MAPK-STAT3 pathway. Binding of transcription factor STAT3 to the iNOS promoter is mediated by PLD2 | Mus musculus |